Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1544716

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1544716

U.S. Vitrification Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2550
PDF & Excel (Multi User License)
USD 3050
PDF & Excel (Enterprise User License)
USD 5050

Add to Cart

U.S. vitrification market size is poised to witness a 9.8% CAGR between 2024 and 2032 driven by the urgent need for effective and sustainable hazardous waste management solutions.

Vitrification offers the unique ability to immobilize contaminants, making it a preferred method for handling radioactive and toxic waste while effectively preventing environmental contamination. With the U.S. tightening its environmental regulations and emphasizing safe disposal methods, there has been a surge in demand for vitrification technologies. These technologies promise long-term stability and a diminished risk of leakage or groundwater contamination.

Advancements in vitrification, including enhanced furnace designs and more efficient processes, are boosting both the effectiveness and cost-efficiency of waste treatment. Furthermore, increased funding from both government and private sectors for waste remediation projects, coupled with the pressing need to tackle legacy waste sites, bolsters the adoption of vitrification solutions.

The overall industry is classified into product type, specimen, end-user, and zone.

Based on product type, the U.S. vitrification market size from the kits segment is anticipated to witness growth through 2032. This surge is attributed to the rising demand for portable, user-friendly, and cost-effective vitrification solutions. Vitrification kits stand out for their flexibility and convenience in managing hazardous waste. They serve as practical tools for emergency responses, decommissioning projects, and smaller remediation efforts, enabling efficient waste treatment without the need for extensive infrastructure.

In terms of end use, the U.S. vitrification market from the biobanks segment is predicted to record notable gains up to 2032. This growth is linked to the critical need for preserving biological samples and ensuring their integrity over extended periods. Vitrification plays a pivotal role in the long-term storage of valuable biological materials, including cells, tissues, and embryos, which are essential for both research and medical applications.

South Atlantic U.S. vitrification industry size will grow significantly through 2032 attributed to the increasing industrial activities and environmental management needs in the region. As South Atlantic regions expand their industrial and energy sectors, there is a growing demand for effective waste management solutions to handle hazardous materials, particularly from sectors, such as mining, energy production, and chemical manufacturing.

Product Code: 10251

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing demand for fertility treatment
      • 3.2.1.2 Expanding biobanking sector
      • 3.2.1.3 Rising awareness and acceptance of IVF
      • 3.2.1.4 Advancements in cryopreservation technologies
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of vitrification procedure
      • 3.2.2.2 Stringent regulatory requirements
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technology landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company market share analysis
  • 4.3 Company matrix analysis
  • 4.4 Competitive analysis of major market players
  • 4.5 Competitive positioning matrix
  • 4.6 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Devices
    • 5.2.1 Open system
    • 5.2.2 Closed system
  • 5.3 Kits
  • 5.4 Reagents and consumables

Chapter 6 Market Estimates and Forecast, By Specimen, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Embryos
  • 6.3 Oocytes
  • 6.4 Sperms

Chapter 7 Market Estimates and Forecast, By End-user, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 In vitro fertilization clinics
  • 7.3 Biobanks

Chapter 8 Market Estimates and Forecast, By Zone, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Northeast
    • 8.2.1 Connecticut
    • 8.2.2 Maine
    • 8.2.3 Massachusetts
    • 8.2.4 New Hampshire
    • 8.2.5 Rhode Island
    • 8.2.6 Vermont
    • 8.2.7 New Jersey
    • 8.2.8 New York
    • 8.2.9 Pennsylvania
  • 8.3 East North Central
    • 8.3.1 Wisconsin
    • 8.3.2 Michigan
    • 8.3.3 Illinois
    • 8.3.4 Indiana
    • 8.3.5 Ohio
  • 8.4 West North Central
    • 8.4.1 North Dakota
    • 8.4.2 South Dakota
    • 8.4.3 Nebraska
    • 8.4.4 Kansas
    • 8.4.5 Minnesota
    • 8.4.6 Iowa
    • 8.4.7 Missouri
  • 8.5 South Atlantic
    • 8.5.1 Delaware
    • 8.5.2 Maryland
    • 8.5.3 Virginia
    • 8.5.4 West Virginia
    • 8.5.5 North Carolina
    • 8.5.6 South Carolina
    • 8.5.7 Georgia
    • 8.5.8 Florida
  • 8.6 East South Central
    • 8.6.1 Kentucky
    • 8.6.2 Tennessee
    • 8.6.3 Mississippi
    • 8.6.4 Alabama
  • 8.7 West South Central
    • 8.7.1 Oklahoma
    • 8.7.2 Texas
    • 8.7.3 Arkansas
    • 8.7.4 Louisiana
  • 8.8 Mountain States
    • 8.8.1 Idaho
    • 8.8.2 Montana
    • 8.8.3 Wyoming
    • 8.8.4 Nevada
    • 8.8.5 Utah
    • 8.8.6 Colorado
    • 8.8.7 Arizona
    • 8.8.8 New Mexico
  • 8.9 Pacific Central
    • 8.9.1 California
    • 8.9.2 Alaska
    • 8.9.3 Hawaii
    • 8.9.4 Oregon
    • 8.9.5 Washington

Chapter 9 Company Profiles

  • 9.1 Biotech, Inc.
  • 9.2 CooperSurgical Fertility Company
  • 9.3 FERTIPRO NV
  • 9.4 FUJIFILM Irvine Scientific
  • 9.5 Genea BIOMEDX
  • 9.6 IMV Technologies Group (Cryo Bio System)
  • 9.7 Kitazato Corporation.
  • 9.8 MFC Global
  • 9.9 MINITUB GMBH
  • 9.10 NidaCon International AB
  • 9.11 Optimas
  • 9.12 Shenzhen VitaVitro Biotech
  • 9.13 Vitrolife
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!